chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came into the pharmacy with her mother to receive the JANSSEN COVID-19 vaccine. Per technician that witnessed the event the patient passed out while next to her mother while walking over to the chair to wait 15 minutes after immunization. The mother started yelling and the patient ended up in the chair, did not fall onto the floor. At this time the senior technician called 911. The patient regained consciousness, was breathing but appeared pale in complexion. The patient verbalized that her heart was racing. EMS arrived, patient was put on oxygen and transported to the hospital.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Apr2022 as dose 2, single (Batch/Lot number: unknown) at the age of 59 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing); "type 2 diabetes" (unspecified if ongoing); "GERD" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Hydrocodone, reaction(s): "known allergies: hydrocodone"; Tapentadol, reaction(s): "known allergies: tapentadol". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective and covid-19 with Paxlovid from 04Jan2023 to 05Jan2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
65F with HTN, numerous drug and medication allergies, presents to ED with complaints of chest tightness and palpitations after receiving her 2nd COVID vaccination shot 10 min prior to ED arrival. Pt reports that this is how she felt after she got her flu shot and she typically takes prednisone and symptoms abate. Pt denied having any chest tightness here in ED. No fevers, no coughing, no rashes, no pruritis.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:12/24/20,Pfizer,Lot# EK9231 2nd dose: 01/14/21,Pfizer,Lot# EL3247 Diagnosed covid positive:04/19/2021 Exposure:Unknown Symptoms:Cough,loss of smell/taste
Arthritic swelling in her finger; This spontaneous case was reported by a pharmacist and describes the occurrence of ARTHRITIS (Arthritic swelling in her finger) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (Arthritic swelling in her finger). At the time of the report, ARTHRITIS (Arthritic swelling in her finger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided.   Treatment information was not provided.
Patient got vaccine on 1/9/20; on 1/12/20, they called, saying that on 1/11/20, they started getting a red, swollen and slightly tender arm. They said that it was getting larger today. I recommended that patient use OTC pain meds and/or ice pack for symptoms, and to let us know if it doesn't start going down by tomorrow.
Pt got vaccine at pharmacy off site clinic - this is notes from clinic staff "summary - pt was unable to speak and became somewhat unresponsive 15 minutes after 2nd Pfizer covid dose. family informed clinic staff after he had returned to the car.  history of hypertension/diabetes/kidney transplant.   Insulin was administered this morning.  911 was immediately called, taken to er.  current condition unknown.  blood glucose was 500+ when paramedics checked"
Information has been received from a physician concerning a patient who on 23-MAR-2007 was vaccinated with a dose of Zostavax when varicella (MSD) was ordered. No adverse experience was related to this event. The physician reported that this was not product confusion, but related to staff misinformation. A product quality complaint was not involved.  Additional information has been requested.
On Dec. 14 I noticed a very itchy spot on back of thigh. Scratched, forgot about it. On the evening of Dec. 15 I got home from work and felt like I was itching all over - and once I started I couldn't stop. I took Benadryl trying to calm it. The itchiness & redness moved (and is still moving) all over my body and I tried to identify an environmental cause but nothing jumped out at me that had been changed, and I had never had this sort of apparent allergic reaction before. On Dec. 20 I was seen by PA-C and she said I was her third patient with similar symptoms occuring shortly after receiving a Moderna booster - she point-blank asked me if I had recently been boosted with Moderna before I even had a chance to volunteer it. Today jan 5 I had blood drawn to look for other possible causes, as the itchiness has recently returned with a vengeance after somewhat calming down. But throughout this whole timeframe I have had red spots that come & go throughout the day -sometimes in spots where pressure has been applied (such as from my pants) and sometimes in totally random areas. Most common places for itchiness is my wrists, backs of calves, armpits & groin area.
5JUN98 pt states inj site size of a fifty cent piece & warm to touch;medical MD seen today-MD dx sterile abscess & placed ATB;whole right side of body hurt from abscess-took ATB for 7 days got better no more problems;
This spontaneous report as received from a consumer refers to a 12 month old female patient concerning her daughter. Patient had no pertinent medical history and drug allergies. On 03-FEB-2014 the patient was vaccinated with VARIVAX (merck) (strength, dose number, dose unit, lot# and expiry date unknown), intramuscular. Concomitant therapies included M-M-R II,  TDAP (manufacture unknown) and hepatitis A vaccine (manufacture unknown) on the same day. Consumer reported that when the medical assistant, administered the VARIVAX (merck), it was done with a 1 inch needle and administered intramuscularly at a 90 degree angle. While the medical assistant was trying to administer the VARIVAX (merck) into her daughter's thigh, somehow the VARIVAX (merck) sprayed out from the syringe like a garden hose and shot into the consumer right eye. The patient did not get the full dose and another dose of VARIVAX (merck) was administered to the patient at this same visit. No treatment was given for the event and no laboratory tests were performed. Consumer also noted that another medical assistant administered PROQUAD and VARIVAX to an unspecified 12 month old patient on an unspecified date which was captured in case# 1403USA002425. No further information was provided. This case# 1402USA002360 has been linked to case #1402USA007700 via same reporter link. Follow up information was received from the consumer refers to her 1 year old (initial reported as 12 months old) daughter with one sibling. On 03-FEB-2014 5:00 pm, the patient was vaccinated with a dose of VARIVAX (merck) (lot # H017133, expiry date unspecified) intramuscular in the right thigh (dose not reported). Concomitant therapies included M-M-R II (lot # J006994, expiry date 14-JUN-2015) subcutaneous in the right thigh (dose not reported), DTAP (lot # AC14B177BA, expiry date unspecified) intramuscular in the left thigh (dose not reported) and VAQTA (lot # J003719, expiry date 27-SEP-2015) intramuscular in the left thigh (dose not reported) vaccinated at the same day. On 03-FEB-2014 5:00 pm, when the medical assistant, administered the VARIVAX (merck), it was done with a 1 inch needle and administered intramuscularly at a 90 degree angle. While the medical assistant was trying to administer the VARIVAX (merck) into her daughter's thigh, somehow the VARIVAX (merck) sprayed out from the syringe like a garden hose and shot into the consumer right eye (which was captured in case# 1402USA007700). This caused mild irritation. The mother proceeded to flush eye and had routine eye exam the following day. The exam was normal. Additional information is not expected.
had site injection soreness like last time; issues with her sinuses; headache; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL8982), via an unspecified route of administration on 13Jan2021, (at the age of 48-year-old) as single dose for COVID-19 immunization. The patient's medical history included type 2 diabetes mellitus which was diagnosed probably more than 10 years, hypertension for which she was taking high blood pressure medication for 5-6 years and sleep apnoea syndrome. Consumer says they have had no other recent vaccinations or new medications. After the first dose of vaccine patient had injection site soreness. Patient had a headache prior to getting her second dose of the vaccine, as she had issues with her sinuses, so she took medicine before getting the second dose of vaccine because she assumed it was sinuses. There was no further details provided about medication she took for her sinuses. The patient underwent lab tests and procedures which included blood cholesterol was normal, blood glucose abnormal was normal, blood pressure measurement was normal. The patient received unspecified medication for the headache and sinus. The clinical outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
On June 17 I went to the ER.  Based on the symptoms  I had a CT scan.  I had a Bi-lateral Pulmonary Embolism with a Saddle Embolism.  I was put on Heprin.  Based on my Troponin numbers there was damage done to the right side of heart. I spend 4 days in the Hospital.  I was released on the 21st of June.  I have many doctor appointments scheduled including:  cardiologist, phlebotomist, and Primary Physician.   I have been sent home with Eliquis and will be on it for the foreseeable future.   Days in Hospital:  4
Per nursing note, patient "Pt received TWINRIX and tdap IM per order. Pt received TWINRIX in right deltoid and immediately started to exhibit a light convulsion lasting 5-5.5 seconds and slumped forward. Pt then sat up and was talking coherently. She denied any allergies. Vital signs were stable at 119/70 with a pulse of 58 and respirations of 16 and unlabored." "exhibited a strong, steady gait." "all neuro checks were within normal limits."
After vaccination, I had all of the expected symptoms for about a week.  After a week, the symptoms all went away except for pain in my arm at and near the injection site (high up near the front of my arm) and inability to move my arm in all directions.  After 4 months, my arm still hurts and does not have complete range of motion.  I have just started physical therapy (2 sessions so far) with no relief yet.
Post second dose on July 19, 2000 within 24 hours, she started to develop symptoms that were characterized as fever, malaise, headaches, conjunctivitis of her left eye and a rash that progressively involved her entire body. Her symptoms were relentless and did not abate and for this reason on July 28th, 2000, she went to ER and was evaluated and found a generalized rash to be present. The clinical diagnosis of erythema multiforme was given with possible vasculitis. At that point in time, she was started on Solu-Medrol and Levaquin. This apparently induced some remission of her symptoms, however, the symptoms came back after the effects of the Corticosteroid wore off. Her symptoms were severe enough on July 31,2000, for her to go back to ER. At that point in time, she was rechecked at another facility with rash, headaches and fever. She was again diagnosed as having   erythema multiforme and at that point in time, she was discharged to her family. She returned to the ER on August 5, 2000. At that point in time, her symptoms returned. She complained of rash located on her whole body and the fever was no longer present. At that point in time, she was given Solu-Medrol again and was advised to follow up with her personal doctor. On Aug 15, 2000, she was evaluated and found to have a clinical picture consistent with Stevens-Johnson syndrome. At that, point in time, she was referred to an allergist and was advised to stop all medications. In that interim of time, essentially the last two and a half weeks, her symptoms have gradually subsided but not completely with still scars present over areas where the rash was present.
felt as if "tons of bricks hit her"; irritable; sweating; hands clammy; feel tired; chills on and off; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy) and FATIGUE (feel tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off). At the time of the report, FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy) and FATIGUE (feel tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off). At the time of the report, FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported.  No treatment information was provided.
I was very tired and exhausted for two full days. I have shortness of breath and have a cough.
7/20--currently admitted 84y.o. female with a PMH significant for atrial fibrillation, metastatic ovarian cancer on chemotherapy, pulmonary hypertension, HFpEF, who was recently hospitalized for COVID pneumonia 7/20, who presents with shortness of breath, weakness. During previous admission, patient was treated with loading dose of remdesivir, her oxygen saturations remained appropriate, and she was discharged. Patient's respiratory status began to deteriorate and she became progressively more weak with watery diarrhea and fever at home. Given her worsening respiratory status, her daughter-in-law and son felt as if they could no longer care for her appropriately, and brought her to the hospital to be evaluated. In the ED, lab work was notable for elevated troponin, elevated inflammatory markers, and pancytopenia. CXR was obtained. EKG with normal sinus rhythm with some ST-T wave depressions in leads II, III, to aVF. She was then admitted to the Medicine team for further evaluation and management of shortness of breath and weakness. Remdesivir and antibiotics 5 day courses were completed. CTA confirmed subsegmental pulmonary embolism in the right posterior lower lobe. Patient was transfused 1 unit of platelets followed by IV heparin initiation. 2D echo was notable for EF 40%, mild mitral and tricuspid regurgitation, multiple wall motion abnormalities, and left pleural effusion. Coreg 3.125 mg BID was started. Sotalol was switched to amiodarone given reduced EF. On 07/27, patient had new onset left sided abdominal pain with significant decrease in Hgb and BP secondary to retroperitoneal bleed confirmed by CTA.  IV heparin was immediately discontinued. 1 L bolus and 500 mL bolus were given as well as 2 units PRBCs. Interventional radiology embolized bilateral lumbar arteries. Hemoglobin stabilized around 7.5. Patient was initiated on Lovenox. Hematology is recommending that she be maintained on subcutaneous Lovenox 40 mg upon discharge for prophylaxis. Patient with persistent urinary retention while admitted and was thought to be associated with her mirabegron which was discontinued. She continued to have urinary retention and a foley was placed on 8/1 and urology was consulted for their recommendations. A bilateral lower extremity doppler was ordered to determine if patient needs an IVC filter. PT/OT recommend patient be discharged to SAR when medically stable. Patient has been non ambulatory while admitted secondary to deconditioning after being diagnosed with COVID.
Headache, knees, back, shoulders, wrist, forearm, tiredness, chills and mostly pain that continues.
Started to feel sick Tuesday but I thought it was due to pollen I had a temperature, and my throat was sore. Went you the doctor and discovered it was COVID-19 and was given PAXLOVID. I took the medication for 5 days and I was given cough medication. I did recover after taking the medication.
For a couple of days after immunization low grade fever then on 25th complained of bump in groin that was tender. Child has firm swollen glands in both sides of neck and right side of groin.  No other apparent side effects.
01Sept95 recv 1 dose vax. Concomitant vax; 4th dose haemophilus b conjugate vax & 1 dose MMR (2nd generation, MSD). 12Jan98 pt devel chickenpox. Less than 20 lesions. 3 siblings reported similar exp (WAES98011240, 98011483, 98011484).
Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: Patient reported swelling of lips and eyes several hours after injection. She did not require medical attention or experience difficulty breathing.
Client stated that her throat felt like it was swelling. Administered 50 mg Benadryl without resolution. Epipen administered and EMS called. EMS released client after 30 minutes.
Fatigue, skin rash on area where I got the shot, face, scalp breakout with lumps, lips got bigger, shortness of breath and felt like my throat closed up. I was hoarse with a sore throat, throat dry, nausea and vomiting.
Metallic taste on mouth; Pain on injection site; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste on mouth) and VACCINATION SITE PAIN (Pain on injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     no medical history was reported by reporter.  Concomitant products included VITAMIN D NOS for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced DYSGEUSIA (Metallic taste on mouth) and VACCINATION SITE PAIN (Pain on injection site). At the time of the report, DYSGEUSIA (Metallic taste on mouth) and VACCINATION SITE PAIN (Pain on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medicine includes thyroid medicine (unspecified) Over-the-counter medication for heartburn Cholesterol medication.  treatment information was not provided   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Significant arm pain which made it impossible to move arm, diarrhea, head ache, generalized muscle pain, fatigue.
sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th February 2020, the patient received the 1st dose of Shingrix. On 9th February 2020, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The patient recived Shingrix and experienced sore arm. The reporter consented to follow up. For tolerance after 2nd dose refer case US2020123381.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020123381:same reporter
Patient received SHINGRIX vaccine. Shortly after expired high fever and bloody urine that persisted for 5 weeks off and on.
It was reported that a 15month old male patient received a Tripedia vaccination ,lot 3 UO532CA, given IM in his left thigh on 09/12/01. On 09/13/01, the patient's leg became swollen at the thigh all the way to the top of the knee, thigh was red and warm. Treatment of Ibuprofen 100 mg per oral every 6-8 hours PRN and cool compresses PRN was given to the patient. He recovered from this experience.